Catalyst Repository | Benitec Biopharma Inc. Common Stock

Benitec Biopharma Inc. Common Stock

(NASDAQ:BNTC)

Description

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.

BNTC Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$0.2099
Previous Close Volume
225460


Latest News